참고문헌
- Yoo KH, Kim YS, Sheen SS, Park JH, Hwang YI, Kim SH, et al. Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology 2011;16:659-65. https://doi.org/10.1111/j.1440-1843.2011.01951.x
- Lee J, Lee JH, Kim JA, Rhee CK. Trend of cost and utilization of COPD medication in Korea. Int J Chron Obstruct Pulmon Dis 2017;12:27-33.
- Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442. https://doi.org/10.1371/journal.pmed.0030442
- Lee JY, Rhee CK, Jung KS, Yoo KH. Strategies for management of the early chronic obstructive lung disease. Tuberc Respir Dis 2016;79:121-6. https://doi.org/10.4046/trd.2016.79.3.121
- Organisation for Economic Co-operation and Development. Health at a glance 2015: OECD indicators. Paris: OECD; 2015.
- Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J 2017;49:1700214. https://doi.org/10.1183/13993003.00214-2017
- Health Insurance Review & Assessment Service. Evaluation of appropriate management of COPD in Korea 2017 [Internet]. Wonju: Health Insurance Review & Assessment Service; 2017 [cited 2017 May 1]. Available from: http://www.hira.or.kr/re/diag/getDiagEvlList.do?pgmid=HIRAA030004000000&WT. ac=%EB%B3%91%EC%9B%90%ED%8F%89%EA%B0%80.
- Beeh KM. The role of bronchodilators in preventing exacerbations of chronic obstructive pulmonary disease. Tuberc Respir Dis 2016;79:241-7. https://doi.org/10.4046/trd.2016.79.4.241
피인용 문헌
- Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study vol.19, pp.None, 2017, https://doi.org/10.1186/s12931-018-0896-7
- Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea vol.82, pp.1, 2017, https://doi.org/10.4046/trd.2018.0035
- The effect of low body mass index on the development of chronic obstructive pulmonary disease and mortality vol.286, pp.5, 2019, https://doi.org/10.1111/joim.12949
- Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters vol.34, pp.6, 2017, https://doi.org/10.3904/kjim.2019.327
- Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease vol.10, pp.None, 2017, https://doi.org/10.1038/s41598-020-63064-x
- Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan vol.16, pp.None, 2021, https://doi.org/10.2147/copd.s329454
- Cut-off value of FEV1/FEV6 to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease vol.36, pp.3, 2017, https://doi.org/10.3904/kjim.2019.314
- The nationwide retrospective cohort study by Health Insurance Review and Assessment Service proves that asthma management decreases the exacerbation risk of asthma vol.11, pp.1, 2017, https://doi.org/10.1038/s41598-021-81022-z
- Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-94385-0
- Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease vol.22, pp.1, 2017, https://doi.org/10.1186/s12931-021-01684-1